丹红注射液联合低分子肝素治疗老年肺栓塞32例临床研究  

Clinical Efficacy of Danhong Injection Combined with Low Molecular Heparin in Treating Senile Pulmonary Embolism in 32 Cases

作　　者：贺霞[1] 

机构地区：[1]四川省德阳市第二人民医院,四川德阳618000

出　　处：《中国药业》2015年第4期29-30,共2页China Pharmaceuticals

摘　　要：目的探讨丹红注射液联合低分子肝素治疗老年肺栓塞的临床疗效。方法回顾性分析医院2008年10月至2013年10月收治的老年肺栓塞患者63例的临床资料,所有患者均给予常规治疗,对照组31例加用低分子肝素治疗,治疗组32例加用丹红注射液联合低分子肝素治疗,比较两组患者的临床疗效。结果治疗组总有效率为93.75%,明显高于对照组的87.10%(P<0.05);治疗后两组患者的凝血酶原时间(PT)和纤维蛋白原(Fg)均增加,且治疗组明显高于对照组(P<0.05)。结论丹红注射液联合低分子肝素治疗老年肺栓塞效果良好,值得临床推广。Objective To investigate the clinical efficacy of Danhong Injection combined with low molecular heparin in treating senile pulmonary embolism. Methods The clinical data of 63 patients with senile pulmonary embolism in our hospital from October 2008 to October 2013 were retrospectively analyzed. All cases were given the routine therapy,31 cases in the control group were added with low molecular heparin and 32 cases in the treatment group were added with Danhong Iinjection combined with low molecular heparin. Then the effects were compared between the two groups. Results The total effective rate in the treatment group was 93. 75%,which was significantly higher than 87. 10% in the control group（ P〈 0. 05）; the levels of PT and Fg in the two groups were increased,but the treatment group was significantly higher than the control group（ P〈 0. 05）. Conclusion Danhong Injection combined with low molecular heparin has better effect for treating senile pulmonary embolism,which is worthy of clinical promotion.

关 键 词：肺栓塞 丹红注射液 低分子肝素 

分 类 号：R285.6[医药卫生—中药学] R286[医药卫生—中医学]